UNIT 4.8 In Vitro Opioid Receptor Assays

Although opioid analgesics have been used for centuries, identification of opioid receptors and the ability of an opioid receptor antagonist to block natural pain processes prompted a search for endogenous opioid peptides. In vitro models were needed to characterize opioid activity in biological samples. The longitudinal muscle/myenteric plexus (LM/MP) of the guinea pig ileum was the classical in vitro assay system, but the development of the mouse vas deferens (MVD) assay provided another important model that could be employed. Both assays entail electrical stimulation of intramural nerves to produce muscle contractions of the target organ. The robust contractions of the LM/MP are inhibited by µ and opioid receptor agonists, while the more labile contractions of the MVD are inhibited by µ, , and opioid receptor agonists. These in vitro assay systems are useful for evaluating biological activity of unknown substances and studying the properties of drug tolerance and both are described in this unit. Curr. Protoc. Pharmacol. 55:4.8.1-4.8.34. © 2011 by John Wiley & Sons, Inc.

Keywords: opioid receptors; mu opioid receptors; kappa opioid receptors; delta opioid receptors; in vitro assays; mouse; guinea pig; longitudinal muscle/myenteric plexus; vas deferens